Deb Autor, Chief Executive Officer, Healthcare Innovation Catalysts
With over 30 of experience at the highest levels of government and regulated industry, Deb Autor brings an unparalleled range of expertise across regulatory, quality, compliance, business strategy, policy, and law. This breadth and depth of experience, combined with HIC’s deep bench of cross-functional technical expertise, makes HIC a sought-after advisor in both the private and public sectors. Deb’s government career spanned two decades, culminating as Deputy Commissioner of the Food and Drug Administration. In that role, Deb oversaw all the agency’s inspections and international operations, directing 4,500 employees in the FDA’s Office of Regulatory Affairs and Office of International Programs. Prior to that, Deb was Director of the Office of Compliance in FDA’s Center for Drug Evaluation and Research, where she led enforcement and policy making for compliance with all drug requirements, including drug approval; current good manufacturing practices (GMP); human subject protection and bioresearch monitoring (GCP); import and export; and recalls. Before she joined FDA, Deb was a Trial Attorney at the U.S. Department of Justice, where she was first chair for dozens of civil and criminal cases on behalf of FDA.
